Alterola Biotech Inc. financial data

Symbol
ABTI on OTC
Industry
Medicinal Chemicals & Botanical Products
Location
47 Hamilton Square, Birkenhead Merseyside, United Kingdom
Fiscal year end
March 31
Former names
JEDEDIAH RESOURCES CORP. (to 11/19/2010)
Latest financial report
10-Q - Q2 2024 - Aug 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.22 % -62.6%
Quick Ratio 0.06 % +19.7%
Debt-to-equity -108 % -1837%
Return On Equity 151 %
Return On Assets -1.82K % +86.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.47B shares +81.8%
Common Stock, Shares, Outstanding 1.47B shares +81.8%
Entity Public Float 253K USD -97.6%
Common Stock, Value, Issued 1.47M USD +81.8%
Weighted Average Number of Shares Outstanding, Basic 803M shares +6.41%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 19.1K USD
General and Administrative Expense 6.97K USD -83.2%
Operating Income (Loss) -1.97M USD -9.15%
Net Income (Loss) Attributable to Parent -2.35M USD -37.6%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Inventory, Net 1.01K USD +0.2%
Assets, Current 12K USD -94.8%
Deferred Income Tax Assets, Net 187K USD +41.9%
Assets 12K USD -5.73%
Accounts Payable, Current 866K USD +27.7%
Accrued Liabilities, Current 490K USD +73.1%
Liabilities, Current 1.51M USD -35.4%
Liabilities 1.51M USD -35.4%
Retained Earnings (Accumulated Deficit) -12.8M USD -24.7%
Stockholders' Equity Attributable to Parent -1.5M USD -115%
Liabilities and Equity 12K USD -5.73%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 55.6K USD -82.1%
Net Cash Provided by (Used in) Financing Activities 6.14K USD
Net Cash Provided by (Used in) Investing Activities -167K USD
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 1.47B shares +81.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 61.7K USD -41.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11K USD -70%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -473K USD +9.93%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -5.83K USD
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 9.89M USD -50.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 189K USD
Interest Expense -38 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%